Dragon Fruit (Pitaya)
Betalain-rich cactus fruit for vascular health
Nutrition per serving 1 medium (227 g)
- Water 190.7 g83%
- Sugars 22.1 g10%
- Fibre 7 g3%
- Other carbs 5.4 g2%
- Protein 2.5 g1%
- Fat 0.8 g0%
| Nutrient | Per serving | % daily value |
|---|---|---|
| Fiber | 7 g | 25% |
| Vitamin C | 9.8 mg | 11% |
| Magnesium | 16 mg | 4% |
| Iron | 0.41 mg | 2% |
| Potassium | 263 mg | 6% |
| Calcium | 20 mg | 2% |
| Phosphorus | 27 mg | 2% |
| Sugars | 22 g | 0% |
Composition data: USDA FoodData Central ↗
What is Dragon Fruit (Pitaya)?
Dragon Fruit (Pitaya) (Hylocereus undatus / H. polyrhizus) is a fruit used for improved endothelial/vascular function (flow-mediated dilation, pulse-wave velocity, arterial stiffness) in a single small controlled human crossover trial using betalain-rich fruit powder. NutriDex grades the human evidence as Preliminary. Dragon fruit is a low-calorie, fiber- and vitamin-C-containing cactus fruit whose red-fleshed varieties are notably rich in betalain pigments and phenolic acids with strong in-vitro antioxidant activity. The strongest human data come from a single double-blind randomized crossover trial (n=18) in which 24 g betalain-rich dragon fruit powder (~33 mg betalains) daily for 14 days improved flow-mediated dilation, acutely reduced pulse-wave velocity, and improved augmentation index, suggesting a real but modest vascular benefit. A 2017 meta-analysis of four small RCTs found a significant fasting-glucose reduction in prediabetes (−15.1 mg/dL) but no significant effect in established type 2 diabetes. Dragon fruit oligosaccharides showed prebiotic and immune (IgA) effects in a rat study and a small human trial, and small trials/reviews hint at favorable lipid changes. However, the overall human evidence base is thin: trials are few, small, short, mostly from a handful of research groups, and heterogeneous in form (fresh fruit vs. powder vs. isolated oligosaccharides). Long-term outcomes and effects from realistic dietary portions of whole fruit remain largely unproven, so claims should be considered preliminary.